Global and Region mRNA Vaccine Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of mRNA Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of mRNA Vaccinemarket, defines the market attractiveness level of mRNA Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of mRNA Vaccine industry, describes the types of mRNA Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global mRNA Vaccine market and the development prospects and opportunities of mRNA Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global mRNA Vaccine market in Chapter 13.

    By Player:

    • Sangamo Therapeutics

    • BioNTech

    • eTheRNA

    • CureVac

    • Argos Therapeutics

    • In-Cell-Art

    • Translate Bio

    • Tiba Biotechnology

    • Ethris

    • Moderna Therapeutics

    By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Infectious Disease

    • Cancer

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 mRNA Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 mRNA Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 mRNA Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 mRNA Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise mRNA Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global mRNA Vaccine Consumption (2017-2022)

    • 7.2 United States mRNA Vaccine Consumption (2017-2022)

    • 7.3 Europe mRNA Vaccine Consumption (2017-2022)

    • 7.4 China mRNA Vaccine Consumption (2017-2022)

    • 7.5 Japan mRNA Vaccine Consumption (2017-2022)

    • 7.6 India mRNA Vaccine Consumption (2017-2022)

    • 7.7 South Korea mRNA Vaccine Consumption (2017-2022)

    8 Region and Country-wise mRNA Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.4 China mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.6 India mRNA Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea mRNA Vaccine Consumption Forecast (2022-2028)

    9 Global mRNA Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global mRNA Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global mRNA Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global mRNA Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global mRNA Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global mRNA Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global mRNA Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global mRNA Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global mRNA Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 mRNA Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global mRNA Vaccine Market Competitive Analysis

    • 14.1 Sangamo Therapeutics

      • 14.1.1 Sangamo Therapeutics Company Details

      • 14.1.2 Sangamo Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sangamo Therapeutics mRNA Vaccine Product and Service

    • 14.2 BioNTech

      • 14.2.1 BioNTech Company Details

      • 14.2.2 BioNTech mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BioNTech mRNA Vaccine Product and Service

    • 14.3 eTheRNA

      • 14.3.1 eTheRNA Company Details

      • 14.3.2 eTheRNA mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 eTheRNA mRNA Vaccine Product and Service

    • 14.4 CureVac

      • 14.4.1 CureVac Company Details

      • 14.4.2 CureVac mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 CureVac mRNA Vaccine Product and Service

    • 14.5 Argos Therapeutics

      • 14.5.1 Argos Therapeutics Company Details

      • 14.5.2 Argos Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Argos Therapeutics mRNA Vaccine Product and Service

    • 14.6 In-Cell-Art

      • 14.6.1 In-Cell-Art Company Details

      • 14.6.2 In-Cell-Art mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 In-Cell-Art mRNA Vaccine Product and Service

    • 14.7 Translate Bio

      • 14.7.1 Translate Bio Company Details

      • 14.7.2 Translate Bio mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Translate Bio mRNA Vaccine Product and Service

    • 14.8 Tiba Biotechnology

      • 14.8.1 Tiba Biotechnology Company Details

      • 14.8.2 Tiba Biotechnology mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Tiba Biotechnology mRNA Vaccine Product and Service

    • 14.9 Ethris

      • 14.9.1 Ethris Company Details

      • 14.9.2 Ethris mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ethris mRNA Vaccine Product and Service

    • 14.10 Moderna Therapeutics

      • 14.10.1 Moderna Therapeutics Company Details

      • 14.10.2 Moderna Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Moderna Therapeutics mRNA Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of mRNA Vaccine

    • Figure mRNA Vaccine Picture

    • Table Global mRNA Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global mRNA Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global mRNA Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global mRNA Vaccine Consumption by Country (2017-2022)

    • Figure United States mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea mRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global mRNA Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea mRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global mRNA Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global mRNA Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Sangamo Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Therapeutics mRNA Vaccine Product and Service

    • Table BioNTech (Foundation Year, Company Profile and etc.)

    • Table BioNTech mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioNTech mRNA Vaccine Product and Service

    • Table eTheRNA (Foundation Year, Company Profile and etc.)

    • Table eTheRNA mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table eTheRNA mRNA Vaccine Product and Service

    • Table CureVac (Foundation Year, Company Profile and etc.)

    • Table CureVac mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac mRNA Vaccine Product and Service

    • Table Argos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Argos Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Argos Therapeutics mRNA Vaccine Product and Service

    • Table In-Cell-Art (Foundation Year, Company Profile and etc.)

    • Table In-Cell-Art mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table In-Cell-Art mRNA Vaccine Product and Service

    • Table Translate Bio (Foundation Year, Company Profile and etc.)

    • Table Translate Bio mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Translate Bio mRNA Vaccine Product and Service

    • Table Tiba Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Tiba Biotechnology mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiba Biotechnology mRNA Vaccine Product and Service

    • Table Ethris (Foundation Year, Company Profile and etc.)

    • Table Ethris mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethris mRNA Vaccine Product and Service

    • Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Moderna Therapeutics mRNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics mRNA Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.